UBS adjusted its price target on United Therapeutics on June 30, 2025.
1 report, 0 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UBS adjusted its price target on United Therapeutics on June 30, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
UBS
Swiss multinational investment bank and financial services company
-
United Therapeutics
biotech company based in Silver Spring, Maryland, United States
Related events
- MiniMed Group received multiple target price increases from UBS, Morgan Stanley, and Deutsche Bank, and submitted a product to the FDA.
- Wholesale Club filed a disclosure document with the SEC, coinciding with UBS increasing its price target.
- UBS raised its price objective for Petrobras stock.
- UBS analysts focused on Costco's membership growth while Bank of America trimmed its price target due to a cautious view.
- UBS raised its price target on SolarEdge stock on August 25, 2025.
Coverage
Newest first; wire copies grouped- Unknown outlet